Apprise News
Subscribe

Questions & answers

Your questions: New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine

Compiled Aug 7

When exactly will mFlusiva become available at retailers?

The reporting doesn’t answer this yet.

What were the specific reasons the FDA official initially blocked the application?

Earlier this year a then-top FDA official blocked Moderna's application, then the agency reversed course after Moderna publicly challenged the ruling

What will the additional study for the 65+ accelerated approval show?

The FDA granted full approval for use in people ages 50-64 based on a study showing 27% fewer flu cases compared with a different common flu vaccine

How will mFlusiva's price or availability compare with existing flu vaccines?

For people 65 and older, the FDA granted accelerated approval based on a smaller study showing a strong immune response compared with an existing high-dose vaccine for seniors

Read the full story →